Literature DB >> 7544249

Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C.

P M Yang1, L H Hwang, M Y Lai, W L Huang, Y D Chu, W K Chi, B L Chiang, J H Kao, P J Chen, D S Chen.   

Abstract

The proliferative response of peripheral blood mononuclear cells (PBMC) to a recombinant non-structural (NS3) protein of hepatitis C virus (HCV) was studied in 41 patients with chronic hepatitis C. Of them, 28 had chronic persistent hepatitis (CPH) and 13 chronic active hepatitis (CAH). The positive proliferation rate of PBMC to the recombinant NS3 protein, T9Ag, was 66% in the 41 patients (77% in CAH versus 61% in CPH; P > 0.05) when stimulation index (SI) = 4 was set as the cut-off value. However, mean SI of CAH patients was significantly higher than that of CPH patients (8.3 +/- 5.2 versus 5.1 +/- 3.6; P < 0.05). Six other chronic hepatitis patients who were repeatedly negative for anti-HCV antibody but positive for serum HCV RNA also had an SI of > or = 4.0. The frequency of cellular immune response to the T9Ag is among the highest results obtained by using HCV antigens tested so far. Our studies thus indicate that NS3 is an immunologically important region of HCV for T cells. Moreover, the proliferative response to T9Ag may help to establish hepatitis C etiology in chronic hepatitis patients who are seronegative with currently available anti-HCV assays.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544249      PMCID: PMC1553277          DOI: 10.1111/j.1365-2249.1995.tb08350.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis.

Authors:  F Bortolotti; A Tagger; P Cadrobbi; C Crivellaro; F Pregliasco; M L Ribero; A Alberti
Journal:  J Hepatol       Date:  1991-03       Impact factor: 25.083

2.  Non-A, non-B hepatitis and antibody to hepatitis C virus.

Authors:  J W Mosley; R D Aach; F B Hollinger; C E Stevens; L H Barbosa; G J Nemo; P V Holland; W H Bancroft; H J Zimmerman; G Kuo
Journal:  JAMA       Date:  1990-01-05       Impact factor: 56.272

3.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

4.  Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, non-B.

Authors:  H P Dienes; T Hütteroth; G Hess; S C Meuer
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

7.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

8.  Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.

Authors:  D S Chen; G C Kuo; J L Sung; M Y Lai; J C Sheu; P J Chen; P M Yang; H M Hsu; M H Chang; C J Chen
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

9.  Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B.

Authors:  M C Jung; U Spengler; W Schraut; R Hoffmann; R Zachoval; J Eisenburg; D Eichenlaub; G Riethmüller; G Paumgartner; H W Ziegler-Heitbrock
Journal:  J Hepatol       Date:  1991-11       Impact factor: 25.083

10.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

View more
  2 in total

1.  Comparative features of hepatitis C virus infection in humans and chimpanzees.

Authors:  C M Walker
Journal:  Springer Semin Immunopathol       Date:  1997

2.  Association of Rheumatoid Arthritis and Hepatitis B Infection: A Nationwide Nested Case-Control Study From 1999 to 2009 in Taiwan.

Authors:  Ching-Sheng Hsu; Hui-Chu Lang; Kuang-Yung Huang; Hans Hsienhong Lin; Chien-Lin Chen
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.